Vaccines Research
Bacterial Polysaccharides
- Characterization of Bacterial Glycoconjugates and Development of Associated Vaccine Technologies
Wille Vann, PhD - Evaluating the Host and Microbial Factors That Impact the Efficacy of Polysaccharide Vaccines
Mustafa Akkoyunlu, MD, PhD - Biomarkers of Vaccine Safety and Effectiveness for Encapsulated Bacterial Pathogens
Margaret C. Bash, MD, MPH - Studying the Structure of Carbohydrates in Order to Better Understand Bacterial Vaccines and Pathogens
John F. Cipollo, PhD - Improvement of Biological Product Quality by Application of New Technologies to Characterize of Vaccines and Blood Products: NMR Spectroscopy and Light Scattering
Daron Freedberg, PhD
Mucosal Pathogens and Cellular Immunology
- Novel Methods to Detect Malaria Biomarkers for Evaluation of Vaccine Safety and Efficacy
Heather J. Painter, PhD - Identification of Targets for Development of Vaccines and Biological Therapies Against Gastrointestinal Pathogens
Paul E. Carlson Jr., PhD - Bacterial Vaccine Safety: Biomarkers of Virulence and Attenuation in Bordetella Pertussis (Whooping Cough) and Anthrax Bacteria
Scott Stibitz, PhD - Safety and Efficacy of Vaccines Against Intracellular Pathogens: Looking for Signs that Vaccines for Tuberculosis and Other Intracellular Pathogens Will Be Effective
Siobhan C. Cowley, PhD - New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
Karen Elkins, PhD
Respiratory & Special Pathogens
- Improving Vaccine Manufacturing Evaluation for Bacterial Respiratory Pathogens
Drusilla Burns, PhD - Developing and Evaluating Animal Models for Studying the Safety and Efficacy of Vaccines Against Anthrax, Staphylococcal Infections, and Pertussis
Todd Merkel, PhD - Biomarkers of Vaccine Safety and Efficacy for Diphtheria Vaccines
Michael Schmitt, PhD
DNA and Hepatitis Viruses
- Gastrointestinal Viruses: Understanding Diversity and Immune Responses to Inform Vaccine Design
Gabriel I. Parra, PhD - New Approaches to the Development and Evaluation of Human Cytomegalovirus (HCMV) Vaccines
Haruhiko Murata, MD, PhD - Development of Quantitative Assays to Evaluate the Safety of Cell Substrates and Vaccines
Keith Peden, PhD - Development of Assays of Defined Sensitivity for the Regulatory Management of Novel Cell Substrates
Andrew Lewis, MD - New Approaches to the Development and Evaluation of Vaccines Against Hepatitis Viruses
Marian Major, PhD - DNA Virus Vaccines and Vectors
Jerry Weir, PhD
Methods Development
- Evaluation of the Quality of Viral Vaccines Based on Molecular Consistency
Konstantin M. Chumakov, PhD
Pediatric & Respiratory Viral Diseases
- Influenza neuraminidase antigenicity and efficacy in vaccines
Robert Daniels, PhD - Facilitating Influenza Virus Vaccine Production by Optimizing Vaccine Strains
Zhiping Ye, MD, PhD - Developing Tests to Detect Evidence of Protective Immune Responses Generated by Vaccines for Respiratory Viruses That Infect Infants, Children and the Elderly
Judy Beeler, MD
Retrovirus Research
- HIV Influenza And Smallpox Vaccines: Development of New Assays and Animal Models for Evaluation of Vaccine Safety and Efficacy
Hana Golding, PhD - Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans
Arifa Khan, PhD
Vector Borne Viral Diseases
Immunology
- Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated (Weakened), non-HIV Viruses to Express HIV Proteins
Ira Berkower, MD - Evaluating Viral Antigens and Antibody Neutralization for HIV/AIDS, Smallpox, and Influenza
Carol Weiss, MD